Clinical Trial Update: Study of INV-102 Ophthalmic Solution in Adults With Acute Infectious Keratoconjunctivitis [Phase 2]

View source ↗

Summary

This clinical trial update reports that a Phase 2 study of INV-102 Ophthalmic Solution in adults with acute infectious keratoconjunctivitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infectious Keratoconjunctivitis

Drugs mentioned

• INV-102 Ophthalmic Solution (INV-102)

Snippet

Sponsor: Invirsa, Inc. | Conditions: Acute Infectious Keratoconjunctivitis | Phase 2 | Status: COMPLETED